Lake Hills Wealth Management LLC acquired a new position in shares of Centene Corporation (NYSE:CNC – Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 11,528 shares of the company’s stock, valued at approximately $716,000.
A number of other large investors also recently bought and sold shares of CNC. BlackRock Inc. purchased a new position in shares of Centene during the 2nd quarter worth approximately $2,660,422,000. Wellington Management Group LLP grew its stake in shares of Centene by 423.0% in the second quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock valued at $853,805,000 after buying an additional 10,757,914 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Centene by 12.4% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,517,580 shares of the company’s stock valued at $354,173,000 after buying an additional 608,249 shares during the period. Bank of America Corp DE acquired a new position in Centene during the 2nd quarter worth about $285,713,000. Finally, Deutsche Bank AG purchased a new position in Centene during the 2nd quarter valued at about $257,279,000. Institutional investors and hedge funds own 93.63% of the company’s stock.
Centene Stock Up 1.1%
NYSE:CNC traded up $0.69 during trading hours on Wednesday, hitting $65.30. The company’s stock had a trading volume of 1,209,916 shares, compared to its average volume of 5,674,947. The stock has a market capitalization of $32.26 billion, a P/E ratio of -6.26, a price-to-earnings-growth ratio of 0.41 and a beta of 1.13. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.71. The stock has a fifty day moving average of $64.79 and a 200-day moving average of $57.93. Centene Corporation has a 52-week low of $31.63 and a 52-week high of $69.63.
Insider Buying and Selling at Centene
In other news, General Counsel Christopher Koster sold 56,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the completion of the sale, the general counsel owned 248,854 shares in the company, valued at approximately $16,648,332.60. The trade was a 18.50% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.37% of the company’s stock.
Wall Street Analysts Forecast Growth
CNC has been the subject of several recent research reports. Cantor Fitzgerald reissued an “overweight” rating on shares of Centene in a research note on Friday, September 11th. Wells Fargo & Company set a $69.00 price target on shares of Centene and gave the stock an “equal weight” rating in a research note on Monday, July 13th. Morgan Stanley set a $66.00 price objective on Centene in a research note on Wednesday, July 29th. Wall Street Zen raised Centene from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 18th. Finally, TD Cowen reaffirmed a “hold” rating and issued a $65.00 price target (up from $47.00) on shares of Centene in a research report on Tuesday, July 14th. Nine analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $70.05.
Check Out Our Latest Analysis on Centene
About Centene
Centene Corporation (NYSE:CNC) is a healthcare enterprise that provides health insurance and related services, primarily through government-sponsored programs. Its offerings include Medicaid plans, Medicare products, health plans sold through the Affordable Care Act marketplace, and services for military families through government-sponsored healthcare programs.
The company also provides pharmacy, behavioral health, specialty healthcare, care management and administrative services through various subsidiaries and partner organizations.
Featured Stories
- Five stocks we like better than Centene
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
- Morgan Stanley Is Bullish on Apple—But With a Catch
- Disney Is Opening the Door to Netflix—and Changing the Streaming Playbook
- DraftKings Stacks the Deck: The $800M Prediction Pivot
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
